Edition:
United Kingdom

Accuray Inc (ARAY.OQ)

ARAY.OQ on NASDAQ Stock Exchange Global Select Market

3.86USD
19 Jul 2019
Change (% chg)

$0.06 (+1.58%)
Prev Close
$3.80
Open
$3.77
Day's High
$3.94
Day's Low
$3.77
Volume
37,392
Avg. Vol
204,231
52-wk High
$5.39
52-wk Low
$3.01

Latest Key Developments (Source: Significant Developments)

Accuray Inc Reports Q3 Loss Of $0.01 Per Share
Tuesday, 23 Apr 2019 

April 23 (Reuters) - Accuray Inc ::ACCURAY REPORTS FISCAL 2019 THIRD QUARTER RESULTS.Q3 LOSS PER SHARE $0.01.Q3 REVENUE $103.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $103.9 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $-0.04 -- REFINITIV IBES DATA.Q3 ENDING BACKLOG INCREASED 5 PERCENT YEAR OVER YEAR TO $493.9 MILLION.2019 PRODUCT REVENUE GROWTH IS EXPECTED TO RANGE BETWEEN 4 AND 8 PERCENT.2019 SERVICE REVENUE IS EXPECTED TO GROW APPROXIMATELY 2 PERCENT.SEES 2019 TOTAL REVENUE OF BETWEEN $415 MILLION TO $425 MILLION.SEES 2019 ADJUSTED EBITDA OF $23.0 MILLION TO $29.0 MILLION.  Full Article

Phase 3 Randomized Trial Data Shows SBRT Has Similar Acute Safety Profile To Conventional Radiation Therapy In Patients With Localized Prostate Cancer
Friday, 22 Feb 2019 

Feb 22 (Reuters) - Accuray Inc ::PHASE 3 RANDOMIZED TRIAL DATA SHOWS SBRT HAS SIMILAR ACUTE SAFETY PROFILE TO CONVENTIONAL RADIATION THERAPY IN PATIENTS WITH LOCALIZED PROSTATE CANCER.DESPITE HIGH DOSE, USE OF SBRT & CONVENTIONAL RADIATION THERAPY RESULT IN COMPARABLE RATES OF ACUTE GASTROINTESTINAL,GENITOURINARY TOXICITY.  Full Article

Accuray And China Isotope And Radiation Corp Enter Joint Venture Contract
Monday, 28 Jan 2019 

Jan 28 (Reuters) - China Isotope & Radiation Corp <1763.HK>::ACCURAY AND CHINA ISOTOPE AND RADIATION CORPORATION ENTER JOINT VENTURE CONTRACT TO MANUFACTURE AND SELL RADIATION ONCOLOGY SYSTEMS IN CHINA.ACCURAY INC - JV WILL BE LOCATED IN TIANJIN, CHINA AND SALES OPERATIONS ARE EXPECTED TO BEGIN TOWARD END OF CALENDAR 2019.ACCURAY INC - UNDER TERMS OF AGREEMENT, CIRC'S SUBSIDIARY WILL OWN 51% OF JV AND ACCURAY'S SUBSIDIARY WILL OWN REMAINING 49%.ACCURAY INC - ACCURAY AND CIRC BELIEVE THAT JV, WHICH WILL OPERATE UNDER NAME CNNC ACCURAY (TIANJIN) MEDICAL TECHNOLOGY CO., LTD.  Full Article

Accuray Appoints Shig Hamamatsu Chief Financial Officer
Monday, 19 Nov 2018 

Nov 19 (Reuters) - Accuray Inc ::ACCURAY APPOINTS SHIG HAMAMATSU CHIEF FINANCIAL OFFICER.ACCURAY INC - HAS NAMED SHIG HAMAMATSU AS SENIOR VICE PRESIDENT, CHIEF FINANCIAL OFFICER EFFECTIVE IMMEDIATELY.  Full Article

Apollo Hospitals In India To Acquire Two Accuray Radixact Systems
Wednesday, 28 Mar 2018 

March 28 (Reuters) - Accuray Inc ::APOLLO HOSPITALS IN INDIA TO ACQUIRE TWO ACCURAY RADIXACT® SYSTEMS.ACCURAY INC - SIGNED AGREEMENT WITH APOLLO HOSPITALS GROUP IN CHENNAI AND NEW DELHI, INDIA, FOR ACQUISITION OF TWO RADIXACT SYSTEMS.ACCURAY INC - ORDERS WERE ENTERED INTO BACKLOG DURING ACCURAY INCORPORATED'S Q3 FISCAL QUARTER, WHICH ENDS MARCH 31, 2018.  Full Article

Accuray Elects Net Share Settlement For 3.50 Pct Series A Convertible Senior Notes
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - Accuray Inc ::ACCURAY ELECTS NET SHARE SETTLEMENT FOR 3.50% SERIES A CONVERTIBLE SENIOR NOTES DUE 2018.ACCURAY - SPECIFIED CASH AMOUNT FOR EACH $1,000 PRINCIPAL AMOUNT OF SERIES A NOTES CONVERTED WILL BE $1,000.  Full Article

Accuray Inc reports Q1 loss per share $0.11
Tuesday, 24 Oct 2017 

Oct 25 (Reuters) - Accuray Inc :Accuray generated $55.6 million in first quarter gross orders; revenue increased 5 percent year over year.Q1 loss per share $0.11.Q1 revenue $91 million versus I/B/E/S view $88.3 million.Q1 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.Accuray Inc qtrly ‍gross orders increased 11 percent to $55.6 million, net orders were $51.0 million​.Accuray Inc - ‍company is reaffirming revenue, adjusted EBITDA, and gross orders guidance provided on August 22, 2017​.  Full Article